Investment Services News

Sheridan Capital Partners Fund III Closes at Its Hard Cap of $575 Million

Sheridan Capital Partners Fund III Closes at Its Hard Cap of $575 Million

Sixpoint Partners served as exclusive global placement agent

Sixpoint Partners, a leading global investment bank serving the middle market, announced the successful closing of Sheridan Capital Partners Fund III, L.P. (together with its parallel fund, “Fund III” or the “Fund”), at the hard cap with $575 million of total capital commitments.

Latest Fintech Interview: Global Fintech Interview with Paul Monk, Chief Executive Officer at Alpha Development

“We are extremely pleased to have worked with Jonathan, Sean and the rest of the Sheridan team again to help them achieve their second oversubscribed fundraise in a highly competitive environment. This is another example of Sheridan’s continued reputation as a leader in the lower middle market healthcare space”

The Fund was oversubscribed, significantly exceeding its target of $450 million despite the challenging fundraising environment. Sheridan Capital Partners (“Sheridan”) is focused on making investments in lower middle market companies in recession resistant, non-discretionary markets within the healthcare industry. The Fund will continue Sheridan’s strategy of making control investments in North American founder-owned businesses with $3-20 million of EBITDA. Sheridan is led by Partners Jonathan Lewis and Sean Dempsey.

“We deeply value the support we received from our existing investor base for this fundraise, as well as the new strategic partnerships we have created in Fund III, which further diversify our high-quality group of insurance companies, consultants, pensions, family offices, sovereign wealth funds and fund-of-funds across North America, Europe and the Middle East,” said Jonathan Lewis, Partner at Sheridan.

Read More About Fintech Interview: Global Fintech Interview with Michael Rangel, Founder and CEO at Novo

“It has been a great partnership working with Sixpoint on another successful fundraise and we’d like to thank them for their continued commitment and strategic advice,” stated Sean Dempsey, Partner at Sheridan. “We’d also like to thank our limited partners for their critical role in closing Fund III at $575 million. We are very excited about the next phase of growth for our firm as we continue to expand both our team and presence in lower middle market healthcare.”

“We are extremely pleased to have worked with Jonathan, Sean and the rest of the Sheridan team again to help them achieve their second oversubscribed fundraise in a highly competitive environment. This is another example of Sheridan’s continued reputation as a leader in the lower middle market healthcare space,” said Eric Zoller, Founder & Partner at Sixpoint Partners.

“The global demand we saw in the fundraise from both new and existing investors shows the high level of conviction the market has for Sheridan’s team and strategy. We value the partnership and are excited to see the team continue to generate value for their investors,” said Matt Thornton, Partner at Sixpoint Partners.

Browse The Complete Interview About Fintech : Global Fintech Interview with Sankaet Pathak, CEO at Synapse

 [To share your insights with us, please write to sghosh@martechseries.com] 

Related posts

Alpine Immune Sciences Announces Pricing of $150 Million Public Offering

Business Wire

Gunze to Invest 3.5 billion JPY in Establishing Ayabe Plants and R&D Laboratories in Kyoto, Japan for Growth of Medical Business

Business Wire

Walmart to Offer Technologies and Capabilities to Help Other Businesses Navigate their own Digital Transformation

Fintech News Desk
1